Preventive Maximum Gastrointestinal Examination Program

This comprehensive set of tests is designed to assess the function, condition, and possible damage to the digestive system. It combines blood, stool, and cancer marker tests, allowing for a broad and comprehensive examination of the stomach, intestines, liver, pancreas, and bile system. This is particularly useful for those experiencing chronic or recurring digestive disorders.

When is it worth undergoing this examination program?

• When experiencing abdominal pain, bloating, nausea, digestive disorders, or changes in bowel function.
• In case of unexplained gastrointestinal complaints or suspected liver, pancreas, or intestinal diseases.
• When wishing to assess cancer markers prophylactically or to rule out oncological risk.
• When symptoms of intolerance to certain food products occur.
• Suitable as a follow-up test after treatment or if there is a family history of gastrointestinal diseases.

Why choose this?

• The combination of tests allows for the immediate assessment of several organ systems—from enzymes to oncological markers.
• Helps detect inflammatory processes, functional disorders, and possible chronic diseases.
• Includes both blood and stool tests, providing a more comprehensive view of the digestive system's condition.
• Food intolerance testing helps identify products that may cause symptoms.
• Tests are conducted in a single visit, saving time and avoiding fragmented processes.

What does it help to determine?

• ALT, AST, GGT – liver enzymes assessing liver damage, inflammation, or bile duct disorders.
• Pancreatic amylase and lipase – key indicators of pancreatic function.
• Total and direct bilirubin – allows assessment of the liver's ability to process bile and potential liver duct blockages.
• CEA, CA 19-9, CA 50, CA 72-4, AFP – oncological markers useful in assessing the risk of gastrointestinal cancer.
• Coprogram – microscopic stool examination helping to assess digestive efficiency, pancreatic function, inflammation, or parasites.
• H. pylori – bacteria associated with stomach ulcers, gastritis, and stomach cancer risk.
• Calprotectin – an inflammatory bowel biomarker important in inflammatory bowel diseases.
• Fecal occult blood test – helps detect invisible bleeding from the intestines, which can be an early sign of cancer or polyps.